Advancing Cancer Modeling with iPSCs: Current Approaches & Opportunities
- Modeling hereditary cancers using iPSC-derived cancer organoids
- Understanding novel signaling pathways in cancer progression
- Uncovering novel targets for drug and future cell therapies